Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13.

Yan Song Ting Du Arghya Ray Krishan Chauhan Mehmet Samur Nikhil Munshi Dharminder Chauhan Kenneth C Anderson

Blood Cancer J

LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Published: January 2021

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806750	PMC
http://dx.doi.org/10.1038/s41408-020-00398-9	DOI Listing

Publication Analysis

Top Keywords

identification novel

novel anti-tumor

anti-tumor therapeutic

therapeutic target

target proteomic

proteomic characterization

characterization ubiquitin

ubiquitin receptor

receptor adrm1/rpn13

identification

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!